Mkt Cap$2.35T+1.72%
24h Vol$141.79B
BTC Dom56.4%
ETH Dom9.2%
F&G20Extreme Fear
BTC$66,211.00+1.28% ETH$1,790.09+3.81% USDT$0.99940.00% BNB$616.88+0.62% XRP$1.24+5.69% USDC$0.9999+0.01% SOL$73.83+4.73% TRX$0.3189-0.26% FIGR_HELOC$1.03+1.28% HYPE$66.84+5.76% DOGE$0.0881-0.34% USDS$0.9997+0.01% LEO$9.74+0.06% ZEC$516.97+10.62% RAIN$0.0137+4.86% XLM$0.215+14.70% BTC$66,211.00+1.28% ETH$1,790.09+3.81% USDT$0.99940.00% BNB$616.88+0.62% XRP$1.24+5.69% USDC$0.9999+0.01% SOL$73.83+4.73% TRX$0.3189-0.26% FIGR_HELOC$1.03+1.28% HYPE$66.84+5.76% DOGE$0.0881-0.34% USDS$0.9997+0.01% LEO$9.74+0.06% ZEC$516.97+10.62% RAIN$0.0137+4.86% XLM$0.215+14.70%
News

Market Analysis

Total Stories
2,790
Section
Market Analysis
After news came out that Moderna has been secretly working on a Hantavirus vaccine, the MRNA share price rocketed +5%
Market Analysis

Moderna Stock Climbs After Hantavirus Vaccine: Data Triggers Analyst Price Target Hikes

Moderna Stock Rises on Hantavirus Phase 1 Data, Price Targets Hiked

Tim BakerMay 8, 20263 min read